Acarbose and Idiopathic Reactive Hypoglycemia
Generate an AI Snapshot to get a quick, structured summary of this paper.
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
This study found that acarbose is efficacious in the management of idiopathic reactive hypoglycemia, and all patients were asymptomatic on a regular diet.
Abstract
BACKGROUND/AIM: Therapy for idiopathic reactive hypoglycemia is ineffective and impractical. Acarbose, an alpha-glucosidase inhibitor, decreases the absorbed glucose load. This study was done to determine the efficacy of acarbose in this syndrome. METHODS: Six patients with symptoms suggestive of postprandial hypoglycemia were chosen consecutively. Three-hour oral glucose tolerance tests using 75 g of glucose were done on each patient. The patients were then treated with acarbose with each meal. RESULTS: All patients had symptomatic hypoglycemia during testing. After 4 weeks of acarbose therapy, all patients were asymptomatic on a regular diet. CONCLUSION: Acarbose is efficacious in the management of idiopathic reactive hypoglycemia.